Att 2_EIP Published FRN

71799

Federal Register / Vol. 77, No. 233 / Tuesday, December 4, 2012 / Notices
conducted over a 1-day period at each
of nine acute care hospitals in one U.S.
city. This pilot phase was followed in
2010 by a phase 2, limited roll-out HAI
and antimicrobial use prevalence
survey, conducted during July and
August in 22 hospitals across 10
Emerging Infections Program sites (in
California, Colorado, Connecticut,
Georgia, Maryland, Minnesota, New
Mexico, New York, Oregon, and
Tennessee). Experience gained in the
phase 1 and phase 2 surveys was used
to conduct a full-scale, phase 3 survey
in 2011, involving 183 hospitals in the
10 EIP sites. Over 11,000 patients were
surveyed, and analysis of HAI and
antimicrobial use data is ongoing at this
time.
An extension of the prevalence
survey’s existing OMB approval is
sought, to allow a repeat HAI and
antimicrobial use prevalence survey to
be performed in 2014. A repeat survey

will allow further refinement of survey
methodology and assessment of changes
over time in prevalence, HAI
distribution, and pathogen distribution.
It will also allow for a re-assessment of
the burden of antimicrobial use, at a
time when antimicrobial stewardship is
an area of active engagement in many
acute care hospitals. The 2014 survey
will be performed in a sample of up to
500 acute care hospitals, drawn from the
acute care hospital populations in each
of the 10 EIP sites (and including
participation from many hospitals that
participated in prior phases of the
survey). Infection prevention personnel
in participating hospitals and EIP site
personnel will collect demographic and
clinical data from the medical records of
a sample of eligible patients in their
hospitals on a single day in 2014, to
identify CDC-defined HAIs. The surveys
will provide data for CDC to make
estimates of the prevalence of HAIs

across this sample of U.S. hospitals as
well as the distribution of infection
types and causative organisms. These
data can be used to work toward
reducing and eliminating healthcareassociated infections—a Department of
Health and Human Services (DHHS)
Healthy People 2020 objective (http://
www.healthypeople.gov/2020/topics
objectives2020/overview.aspx?
topicid=17). This survey project also
supports the CDC Winnable Battle goal
of improving national surveillance for
healthcare-associated infections (http://
www.cdc.gov/winnablebattles/
Goals.html).
This survey assumes one respondent
per hospital, a median of 75 patients per
hospital, and average data collection
time of 15 minutes per patient. There
are no costs to respondents other than
their time. The estimated annualized
burden is 9,375 hours.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average
burden per
response in
hours

Total burden
(in hours)

Form name

Infection Prevention Personnel in
Participating Hospitals.

Data Collection Form .......................

500

75

15/60

9,375

Total ...........................................

...........................................................

........................

........................

........................

9,375

Dated: November 27, 2012.
Ron Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2012–29173 Filed 12–3–12; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day-13–13DB]

Proposed Data Collections Submitted
for Public Comment and
Recommendations

mstockstill on DSK4VPTVN1PROD with

No. of
respondents

Respondents

In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and

VerDate Mar<15>2010

17:31 Dec 03, 2012

Jkt 229001

instruments, call 404–639–7570 and
send comments to Kimberly S. Lane,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Emerging Infections Program—New—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).

PO 00000

Frm 00028

Fmt 4703

Sfmt 4703

Background and Brief Description
The Emerging Infections Programs
(EIPs) are population-based centers of
excellence established through a
network of state health departments
collaborating with academic
institutions; local health departments;
public health and clinical laboratories;
infection control professionals; and
healthcare providers. EIPs assist in
local, state, and national efforts to
prevent, control, and monitor the public
health impact of infectious diseases.
Various parts of the EIP have received
separate Office of Management and
Budget (OMB) clearances (Active
Bacterial Core Surveillance [ABCs]—
OMB number 0920–0802 and All Age
Influenza Hospitalization
Surveillance—OMB number 0920–
0852); however this request seeks to
have these core EIP activities under one
clearance.
Activities of the EIPs fall into the
following general categories: (1) Active
surveillance; (2) applied public health
epidemiologic and laboratory activities;
(3) implementation and evaluation of
pilot prevention/intervention projects;
and (4) flexible response to public
health emergencies. Activities of the

E:\FR\FM\04DEN1.SGM

04DEN1

71800

Federal Register / Vol. 77, No. 233 / Tuesday, December 4, 2012 / Notices

EIPs are designed to: (1) Address issues
that the EIP network is particularly
suited to investigate; (2) maintain
sufficient flexibility for emergency
response and new problems as they
arise; (3) develop and evaluate public
health interventions to inform public
health policy and treatment guidelines;

(4) incorporate training as a key
function; and (5) prioritize projects that
lead directly to the prevention of
disease. Proposed respondents will
include state health departments who
may collaborate with one or more of the
following: academic institutions, local
health departments, public health and

clinical laboratories, infection control
professionals, and healthcare providers.
Frequency of reporting will be
determined as cases arise. The total
estimated burden is 12,153 hours. There
is no cost to respondents other than
their time.

ESTIMATED ANNUALIZED BURDEN HOURS *
No. of
responses per
respondent

Avg. burden
per response
(in hours)

Total burden
(in hours)

Form name

State Health Department ..................
State Health Department ..................

ABCs Case Report Form .................
Invasive Methicillin-resistant Staphylococcus aureus ABCs Case Report Form.
ABCs Invasive Pneumococcal Disease in Children Case Report
Form.
Neonatal Infection Expanded Tracking Form.
ABCs Legionellosis Case Report
Form.
Campylobacter .................................
Cryptosporidium ...............................
Cyclospora .......................................
Listeria monocytogenes ...................
Salmonella ........................................
Shiga toxin producing E. coli ...........
Shigella .............................................
Vibrio ................................................
Yersinia ............................................
Hemolytic Uremic Syndrome ...........
All Age Influenza Hospitalization
Surveillance Project Case Report
Form.

10
10

809
609

20/60
20/60

2697
2030

10

41

10/60

68

10

37

20/60

123

10

100

20/60

333

10
10
10
10
10
10
10
10
10
10
10

637
130
3
13
827
90
178
20
16
10
400

20/60
10/60
10/60
20/60
20/60
20/60
10/60
10/60
10/60
60/60
15/60

2123
217
5
43
2757
300
297
33
27
100
1000

...........................................................

........................

........................

........................

12,153

State Health Department ..................
State Health Department ..................
State Health Department ..................
State
State
State
State
State
State
State
State
State
State
State

Health
Health
Health
Health
Health
Health
Health
Health
Health
Health
Health

Department
Department
Department
Department
Department
Department
Department
Department
Department
Department
Department

..................
..................
..................
..................
..................
..................
..................
..................
..................
..................
..................

Total ...........................................

Dated: November 27, 2012.
Ron A. Otten,
Director Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2012–29172 Filed 12–3–12; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day-13–0017]

Proposed Data Collections Submitted
for Public Comment and
Recommendations

mstockstill on DSK4VPTVN1PROD with

No. of
respondents

Type of respondent

In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To

VerDate Mar<15>2010

17:31 Dec 03, 2012

Jkt 229001

request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Ron Otten, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to [email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Application for Training (0920–0017,
Expiration 03/31/2013)—Revision—

PO 00000

Frm 00029

Fmt 4703

Sfmt 4703

Scientific Education and Professional
Development Program Office (SEPDPO),
Office of Surveillance, Epidemiology,
and Laboratory Services (OSELS),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC offers public health training
activities to professionals worldwide.
Employees of hospitals, universities,
medical centers, laboratories, State and
Federal agencies, and State and local
health departments apply for training to
learn up-to-date public health practices.
CDC’s training activities include
laboratory training, classroom study,
online training, and distance learning.
CDC uses two training application
forms, the Training and Continuing
Education Online New Participant
Registration Form and the National
Laboratory Training Network
Registration Form, to collect
information necessary to manage and
conduct training pertinent to the
agency’s mission.
CDC requests OMB approval to
continue to collect information through

E:\FR\FM\04DEN1.SGM

04DEN1